We use cookies to offer you an optimal experience on our website. By browsing our website, you accept the use of cookies.

Quan-Yang DUH

Endocrine Surgical and Oncology Clinic
San Francisco, United States
MD
311 likes
13.5K views
0 comments
Filter by
Specialty
View more
Technologies
View more
Lastest Publication
View more
Sort by:
Is minimally invasive thyroidectomy and parathyroidectomy a real progress?
In this video, Dr. QY Duh briefly describes the main principles of MIVAT and MIVAP and compares the novel techniques used for minimal incision thyroidectomy. He presents the advantages, disadvantages and complications of MIVAP & MIVAT, and outlines current innovative approaches for transaxillary thyroidectomy, e.g. robot-assisted BABA, RATS, facelift thyroidectomy, eMIT, TOVAT, TOVANS, and TOETVA. He demonstrates the key steps in the evolution of MIS thyroidectomy from Kocher, mini-incision, MIVAT, extracervical access to NOTES with main advantages of safety –short incision and no neck incision. Finally, he stresses that minimally invasive thyroid surgery is a real progress to evaluate new operations based on safety and efficacy. However, it may not be a real progress in terms of cost and mortality or morbidity.
Lecture
2 years ago
334 views
22 likes
0 comments
19:41
Is minimally invasive thyroidectomy and parathyroidectomy a real progress?
In this video, Dr. QY Duh briefly describes the main principles of MIVAT and MIVAP and compares the novel techniques used for minimal incision thyroidectomy. He presents the advantages, disadvantages and complications of MIVAP & MIVAT, and outlines current innovative approaches for transaxillary thyroidectomy, e.g. robot-assisted BABA, RATS, facelift thyroidectomy, eMIT, TOVAT, TOVANS, and TOETVA. He demonstrates the key steps in the evolution of MIS thyroidectomy from Kocher, mini-incision, MIVAT, extracervical access to NOTES with main advantages of safety –short incision and no neck incision. Finally, he stresses that minimally invasive thyroid surgery is a real progress to evaluate new operations based on safety and efficacy. However, it may not be a real progress in terms of cost and mortality or morbidity.